The risk or severity of adverse effects can be increased when lidocaine is combined with lithium ion.


The risk or severity of adverse effects can be increased when quazepam is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with efavirenz.


The risk or severity of adverse effects can be increased when lidocaine is combined with Butethal.


The risk or severity of adverse effects can be increased when quetiapine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when midazolam is combined with Etidocaine.


The risk or severity of adverse effects can be increased when Flibanserin is combined with citalopram.


The risk or severity of adverse effects can be increased when phenylpropanolamine is combined with METHAMPHETAMINE.


The risk or severity of adverse effects can be increased when mecamylamine is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when mecamylamine is combined with lisinopril.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with spironolactone.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with propranolol.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with Desloratadine.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with clonidine.


The risk or severity of adverse effects can be increased when clozapine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when fenofibrate is combined with fluvastatin.


The risk or severity of adverse effects can be increased when griseofulvin is combined with barnidipine.


The risk or severity of adverse effects can be increased when imipramine is combined with Aliskiren.


The risk or severity of adverse effects can be increased when fenofibrate is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when trimeprazine is combined with trazodone.


The risk or severity of adverse effects can be increased when nystatin is combined with diltiazem.


The risk or severity of adverse effects can be increased when fenoprofen is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when venlafaxine is combined with naratriptan.


The risk or severity of adverse effects can be increased when venlafaxine is combined with rizatriptan.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with METAXALONE.


The risk or severity of adverse effects can be increased when quinapril is combined with antipyrine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with methyldopa.


The risk or severity of adverse effects can be increased when xylometazoline is combined with simvastatin.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with apraclonidine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with Telmisartan.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Articaine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when epoprostenol is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when halcinonide is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when epoprostenol is combined with Eplerenone.


The risk or severity of adverse effects can be increased when epoprostenol is combined with methazolamide.


The risk or severity of adverse effects can be increased when terbinafine is combined with felodipine.


The risk or severity of adverse effects can be increased when Eprosartan is combined with papaverine.


The risk or severity of adverse effects can be increased when Eprosartan is combined with nifedipine.


The risk or severity of adverse effects can be increased when epoprostenol is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when olanzapine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when CYCLIZINE is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when dantrolene is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when clonidine is combined with Eprosartan.


The risk or severity of adverse effects can be increased when dipyridamole is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when pentosan polysulfate is combined with epoprostenol.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with baclofen.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when Etomidate is combined with cocaine.


The risk or severity of adverse effects can be increased when niflumic acid is combined with dexamethasone.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when terbinafine is combined with gabapentin.


The risk or severity of adverse effects can be increased when triazolam is combined with imipramine.


The risk or severity of adverse effects can be increased when ramipril is combined with Sodium aurothiomalate.


The risk or severity of adverse effects can be increased when triazolam is combined with loratadine.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when decamethonium is combined with pilocarpine.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when morphine is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when brotizolam is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Carbetocin is combined with reserpine.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with carisoprodol.


The risk or severity of adverse effects can be increased when retinol is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when sevoflurane is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when temazepam is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when salicylic acid is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when Lofexidine is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when methocarbamol is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when felbamate is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with theobromine.


The risk or severity of adverse effects can be increased when alprazolam is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when captopril is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when ketoprofen is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when zopiclone is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when propranolol is combined with captopril.


The risk or severity of adverse effects can be increased when cerulenin is combined with isradipine.


The risk or severity of adverse effects can be increased when Tapentadol is combined with triamterene.


The risk or severity of adverse effects can be increased when captopril is combined with etodolac.


The risk or severity of adverse effects can be increased when halothane is combined with prazepam.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with diltiazem.


The risk or severity of adverse effects can be increased when nicergoline is combined with efavirenz.


The risk or severity of adverse effects can be increased when nicergoline is combined with testosterone.


The risk or severity of adverse effects can be increased when oxazepam is combined with Perospirone.


The risk or severity of adverse effects can be increased when hydrocortisone is combined with Demecarium.


The risk or severity of adverse effects can be increased when quazepam is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when sumatriptan is combined with mesoridazine.


The risk or severity of adverse effects can be increased when diazepam is combined with carisoprodol.


The risk or severity of adverse effects can be increased when butenafine is combined with nilvadipine.


The risk or severity of adverse effects can be increased when retinol is combined with Isotretinoin.


The risk or severity of adverse effects can be increased when diazepam is combined with sulpiride.


The risk or severity of adverse effects can be increased when ketoprofen is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when perphenazine is combined with proparacaine.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with fluocinonide.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with D-mannitol.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with domperidone.


The risk or severity of adverse effects can be increased when reserpine is combined with meperidine.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when reserpine is combined with prazosin.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when sulconazole is combined with pravastatin.


The risk or severity of adverse effects can be increased when diflunisal is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Paliperidone.


The risk or severity of adverse effects can be increased when pentobarbital is combined with carisoprodol.


The risk or severity of adverse effects can be increased when reserpine is combined with mesoridazine.


The risk or severity of adverse effects can be increased when pentobarbital is combined with sulpiride.


The risk or severity of adverse effects can be increased when dyclonine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when amobarbital is combined with cetirizine.


The risk or severity of adverse effects can be increased when levorphanol is combined with lidocaine.


The risk or severity of adverse effects can be increased when methysergide is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when Fluprednidene is combined with ambenonium.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with D-mannitol.


The risk or severity of adverse effects can be increased when amcinonide is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when halothane is combined with nitrendipine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Halazepam.


The risk or severity of adverse effects can be increased when niflumic acid is combined with flunisolide.


The risk or severity of adverse effects can be increased when etodolac is combined with Apremilast.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with proparacaine.


The risk or severity of adverse effects can be increased when venlafaxine is combined with moclobemide.


The risk or severity of adverse effects can be increased when cabergoline is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when cocaine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when cocaine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when Treprostinil is combined with Olsalazine.


The risk or severity of adverse effects can be increased when cabergoline is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when cabergoline is combined with thiothixene.


The risk or severity of adverse effects can be increased when cocaine is combined with prazepam.


The risk or severity of adverse effects can be increased when cabergoline is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when epirizole is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when timolol is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when Tapentadol is combined with metolazone.


The risk or severity of adverse effects can be increased when Efonidipine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when Phenelzine is combined with bezafibrate.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when dyclonine is combined with cocaine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with vigabatrin.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with benzocaine.


The risk or severity of adverse effects can be increased when desipramine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Paliperidone.


The risk or severity of adverse effects can be increased when pentosan polysulfate is combined with Vorapaxar.


The risk or severity of adverse effects can be increased when barnidipine is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when barnidipine is combined with tolazoline.


The risk or severity of adverse effects can be increased when barnidipine is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Efonidipine.


The risk or severity of adverse effects can be increased when fenoprofen is combined with salicylic acid.


The risk or severity of adverse effects can be increased when fenoprofen is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with alclometasone.


The risk or severity of adverse effects can be increased when temazepam is combined with Lurasidone.


The risk or severity of adverse effects can be increased when phentolamine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when morphine is combined with atenolol.


The risk or severity of adverse effects can be increased when morphine is combined with olanzapine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with nefazodone.


The risk or severity of adverse effects can be increased when Tramadol is combined with Mersalyl.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with doxepin.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with hydromorphone.


The risk or severity of adverse effects can be increased when fenoprofen is combined with fluocinonide.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when salicylic acid is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when gabapentin is combined with levodopa.


The risk or severity of adverse effects can be increased when Tolcapone is combined with isradipine.


The risk or severity of adverse effects can be increased when gabapentin is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when Tramadol is combined with pimozide.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Olmesartan.


The risk or severity of adverse effects can be increased when Tramadol is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when olanzapine is combined with Retigabine.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Pipamperone.


The risk or severity of adverse effects can be increased when isradipine is combined with acebutolol.


The risk or severity of adverse effects can be increased when meperidine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Treprostinil is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when meperidine is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when diflunisal is combined with loteprednol.


The risk or severity of adverse effects can be increased when Efonidipine is combined with LEVOSIMENDAN.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with baclofen.


The risk or severity of adverse effects can be increased when topiramate is combined with maprotiline.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with niflumic acid.


The risk or severity of adverse effects can be increased when Tramadol is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when amifostine is combined with halothane.


The risk or severity of adverse effects can be increased when HEROIN is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when levorphanol is combined with Melatonin.


The risk or severity of adverse effects can be increased when nicergoline is combined with nilvadipine.


The risk or severity of adverse effects can be increased when nicergoline is combined with Fosaprepitant.


The risk or severity of adverse effects can be increased when prazepam is combined with tizanidine.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when levorphanol is combined with promethazine.


The risk or severity of adverse effects can be increased when levorphanol is combined with clonazepam.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with oxprenolol.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when carvedilol is combined with acetylcholine.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with prazepam.


The risk or severity of adverse effects can be increased when losartan is combined with alclofenac.


The risk or severity of adverse effects can be increased when morphine is combined with labetalol.


The risk or severity of adverse effects can be increased when rasagiline is combined with nifedipine.


The risk or severity of adverse effects can be increased when rasagiline is combined with papaverine.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with Nebivolol.


The risk or severity of adverse effects can be increased when morphine is combined with doxazosin.


The risk or severity of adverse effects can be increased when morphine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when morphine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when ISOSORBIDE MONONITRATE is combined with Nebivolol.


The risk or severity of adverse effects can be increased when nabumetone is combined with ibuprofen.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Retigabine.


The risk or severity of adverse effects can be increased when thiothixene is combined with ethosuximide.


The risk or severity of adverse effects can be increased when carprofen is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when Estrone sulfate is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when Levocetirizine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when prazepam is combined with cetirizine.


The risk or severity of adverse effects can be increased when Estrone sulfate is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when prazepam is combined with protriptyline.


The risk or severity of adverse effects can be increased when tacrolimus is combined with bleomycin.


The risk or severity of adverse effects can be increased when tacrolimus is combined with chlorambucil.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with Flupentixol.


The risk or severity of adverse effects can be increased when procarbazine is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with pirenzepine.


The risk or severity of adverse effects can be increased when trimipramine is combined with ethotoin.


The risk or severity of adverse effects can be increased when diflorasone is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with oxazepam.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with doxorubicin.


The risk or severity of adverse effects can be increased when tiapride is combined with Difenoxin.


The risk or severity of adverse effects can be increased when enalapril is combined with Pregabalin.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when dextroamphetamine is combined with AMPHETAMINE.


The risk or severity of adverse effects can be increased when ILOPROST is combined with methazolamide.


The risk or severity of adverse effects can be increased when Clobetasone is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when Clobetasone is combined with galanthamine.


The risk or severity of adverse effects can be increased when ILOPROST is combined with Eplerenone.


The risk or severity of adverse effects can be increased when ILOPROST is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when LISURIDE is combined with alprazolam.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with nisoldipine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when temozolomide is combined with clozapine.


The risk or severity of adverse effects can be increased when carboprost trometamol is combined with dinoprost tromethamine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with flunisolide.


The risk or severity of adverse effects can be increased when tacrolimus is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with efavirenz.


The risk or severity of adverse effects can be increased when thiopental is combined with clonazepam.


The risk or severity of adverse effects can be increased when thiopental is combined with Melatonin.


The risk or severity of adverse effects can be increased when pentobarbital is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Normethadone.


The risk or severity of adverse effects can be increased when HEROIN is combined with METAXALONE.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with methyldopa.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with apraclonidine.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with Telmisartan.


The risk or severity of adverse effects can be increased when propoxyphene is combined with methazolamide.


The risk or severity of adverse effects can be increased when protriptyline is combined with amoxapine.


The risk or severity of adverse effects can be increased when retinol is combined with Acitretin.


The risk or severity of adverse effects can be increased when quazepam is combined with desipramine.


The risk or severity of adverse effects can be increased when quazepam is combined with thiamylal.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when Pramocaine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when furosemide is combined with IDARUBICIN.


The risk or severity of adverse effects can be increased when methadone is combined with triamterene.


The risk or severity of adverse effects can be increased when furosemide is combined with kanamycin.


The risk or severity of adverse effects can be increased when zaleplon is combined with clomipramine.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when ibuprofen is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when zaleplon is combined with Escitalopram.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with loteprednol.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with clonidine.


The risk or severity of adverse effects can be increased when pimozide is combined with enflurane.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with propranolol.


The risk or severity of adverse effects can be increased when ketorolac is combined with flumethasone.


The risk or severity of adverse effects can be increased when furosemide is combined with indapamide.


The risk or severity of adverse effects can be increased when carprofen is combined with alclofenac.


The risk or severity of adverse effects can be increased when Vilazodone is combined with duloxetine.


The risk or severity of adverse effects can be increased when lovastatin is combined with Flibanserin.


The risk or severity of adverse effects can be increased when methadone is combined with pentazocine.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Melatonin.


The risk or severity of adverse effects can be increased when protriptyline is combined with dextromethorphan.


The risk or severity of adverse effects can be increased when mepivacaine is combined with clonazepam.


The risk or severity of adverse effects can be increased when mepivacaine is combined with promethazine.


The risk or severity of adverse effects can be increased when promazine is combined with oxazepam.


The risk or severity of adverse effects can be increased when promazine is combined with nalbuphine.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when paroxetine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Retigabine.


The risk or severity of adverse effects can be increased when Tramadol is combined with amobarbital.


The risk or severity of adverse effects can be increased when oxprenolol is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when methscopolamine is combined with nalbuphine.


The risk or severity of adverse effects can be increased when oxprenolol is combined with doxepin.


The risk or severity of adverse effects can be increased when ILOPROST is combined with Pipamperone.


The risk or severity of adverse effects can be increased when promazine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with albendazole.


The risk or severity of adverse effects can be increased when docetaxel is combined with estramustine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when promazine is combined with thiopental.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when temazepam is combined with Etomidate.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when promazine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Vorapaxar is combined with PENTAERYTHRITOL TETRANITRATE.


The risk or severity of adverse effects can be increased when Clofarabine is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when Etidocaine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Olopatadine.


The risk or severity of adverse effects can be increased when haloperidol is combined with tiagabine.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with butorphanol.


The risk or severity of adverse effects can be increased when haloperidol is combined with zonisamide.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with scopolamine.


The risk or severity of adverse effects can be increased when procyclidine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when MELPERONE is combined with efavirenz.


The risk or severity of adverse effects can be increased when Fospropofol is combined with clomipramine.


The risk or severity of adverse effects can be increased when docetaxel is combined with vinblastine.


The risk or severity of adverse effects can be increased when quinidine is combined with dapsone.


The risk or severity of adverse effects can be increased when DESONIDE is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when methylprednisolone is combined with Demecarium.


The risk or severity of adverse effects can be increased when oxymorphone is combined with ethotoin.


The risk or severity of adverse effects can be increased when flurazepam is combined with amisulpride.


The risk or severity of adverse effects can be increased when Rifampicin is combined with SAQUINAVIR.


The risk or severity of adverse effects can be increased when oxymorphone is combined with prilocaine.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with resveratrol.


The risk or severity of adverse effects can be increased when oxymorphone is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when flurazepam is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Ciclesonide is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when quetiapine is combined with ondansetron.


The risk or severity of adverse effects can be increased when methysergide is combined with lidocaine.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with Riociguat.


The risk or severity of adverse effects can be increased when enalapril is combined with Apremilast.


The risk or severity of adverse effects can be increased when procarbazine is combined with Remoxipride.


The risk or severity of adverse effects can be increased when procarbazine is combined with loxapine.


The risk or severity of adverse effects can be increased when amitriptyline is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when nortriptyline is combined with levodopa.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with levodopa.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with fluocinonide.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when methylergonovine is combined with cyclosporin A.


The risk or severity of adverse effects can be increased when methysergide is combined with nevirapine.


The risk or severity of adverse effects can be increased when methadone is combined with Fospropofol.


The risk or severity of adverse effects can be increased when selegiline is combined with Cariprazine.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with oxyphenonium.


The risk or severity of adverse effects can be increased when Pramocaine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Olopatadine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when levorphanol is combined with potassium ion.


The risk or severity of adverse effects can be increased when hydroxyzine is combined with venlafaxine.


The risk or severity of adverse effects can be increased when isoproterenol is combined with tetrahydrozoline.


The risk or severity of adverse effects can be increased when Remoxipride is combined with trazodone.


The risk or severity of adverse effects can be increased when Naftifine is combined with DESONIDE.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Flibanserin.


The risk or severity of adverse effects can be increased when buprenorphine is combined with Methylnaltrexone.


The risk or severity of adverse effects can be increased when mepivacaine is combined with meclizine.


The risk or severity of adverse effects can be increased when primidone is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when isradipine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when phenmetrazine is combined with acebutolol.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when Benidipine is combined with lovastatin.


The risk or severity of adverse effects can be increased when butorphanol is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when etodolac is combined with dexamethasone.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with xylometazoline.


The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when propoxyphene is combined with doxepin.


The risk or severity of adverse effects can be increased when Conivaptan is combined with atenolol.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with Telmisartan.


The risk or severity of adverse effects can be increased when dyclonine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when protriptyline is combined with efavirenz.


The risk or severity of adverse effects can be increased when Eprosartan is combined with Bretylium.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with gabapentin.


The risk or severity of adverse effects can be increased when oxycodone is combined with meclizine.


The risk or severity of adverse effects can be increased when morphine is combined with ketamine.


The risk or severity of adverse effects can be increased when valsartan is combined with ramipril.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when trimetrexate is combined with nimesulide.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Fospropofol.


The risk or severity of adverse effects can be increased when thalidomide is combined with betaxolol.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with haloperidol.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with thiamylal.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with Tixocortol.


The risk or severity of adverse effects can be increased when nimodipine is combined with labetalol.


The risk or severity of adverse effects can be increased when loxapine is combined with bromazepam.


The risk or severity of adverse effects can be increased when Melatonin is combined with scopolamine.


The risk or severity of adverse effects can be increased when diflorasone is combined with metoclopramide.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with halothane.


The risk or severity of adverse effects can be increased when salicylic acid is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when loxapine is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when Pipamperone is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Pipamperone is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with deslanoside.


The risk or severity of adverse effects can be increased when sulindac is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Remoxipride is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when isoflurane is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when lithium ion is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when propantheline is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when nimodipine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Sacubitril.


The risk or severity of adverse effects can be increased when trimipramine is combined with Frovatriptan.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with paramethasone.


The risk or severity of adverse effects can be increased when lidocaine is combined with butalbital.


The risk or severity of adverse effects can be increased when Flibanserin is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when anagrelide is combined with diflunisal.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with phenindione.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with triamterene.


The risk or severity of adverse effects can be increased when oxymorphone is combined with lidocaine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Potassium citrate.


The risk or severity of adverse effects can be increased when oxymorphone is combined with halothane.


The risk or severity of adverse effects can be increased when pergolide is combined with oxymetholone.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when oxymorphone is combined with thiamylal.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when ATROPINE is combined with hyoscyamine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with methadone.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when isoflurane is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when isoflurane is combined with baclofen.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with olanzapine.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when buspirone is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when losartan is combined with benazepril.


The risk or severity of adverse effects can be increased when isoflurane is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with dexamethasone.


The risk or severity of adverse effects can be increased when phenytoin is combined with Desloratadine.


The risk or severity of adverse effects can be increased when metoprolol is combined with mecamylamine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with norfloxacin.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when methylergonovine is combined with nitrendipine.


The risk or severity of adverse effects can be increased when flurazepam is combined with maprotiline.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when prilocaine is combined with imipramine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when Remoxipride is combined with tiapride.


The risk or severity of adverse effects can be increased when prilocaine is combined with loratadine.


The risk or severity of adverse effects can be increased when aspirin is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with proparacaine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with fenoldopam.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Halazepam.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with butorphanol.


The risk or severity of adverse effects can be increased when rasagiline is combined with hydromorphone.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with indapamide.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when Spirapril is combined with Olopatadine.


The risk or severity of adverse effects can be increased when methazolamide is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with baclofen.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when tetracaine is combined with clonazepam.


The risk or severity of adverse effects can be increased when zaleplon is combined with felbamate.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when formestane is combined with Demecarium.


The risk or severity of adverse effects can be increased when loxapine is combined with midazolam.


The risk or severity of adverse effects can be increased when lorazepam is combined with ethosuximide.


The risk or severity of adverse effects can be increased when clorazepate is combined with thiothixene.


The risk or severity of adverse effects can be increased when isoflurane is combined with prazepam.


The risk or severity of adverse effects can be increased when Bevantolol is combined with Varenicline.


The risk or severity of adverse effects can be increased when carbamazepine is combined with gabapentin.


The risk or severity of adverse effects can be increased when isoflurane is combined with oxprenolol.


The risk or severity of adverse effects can be increased when prednisone is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when amiodarone is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when propofol is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when vigabatrin is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Telmisartan is combined with Propacetamol.


The risk or severity of adverse effects can be increased when nitrazepam is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when Salsalate is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when amisulpride is combined with meclizine.


The risk or severity of adverse effects can be increased when fluoxetine is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when perphenazine is combined with Perospirone.


The risk or severity of adverse effects can be increased when propantheline is combined with Atracurium besylate.


The risk or severity of adverse effects can be increased when fosinopril is combined with epirizole.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with trimetrexate.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with flunarizine.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Droxicam.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when olanzapine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when Nepafenac is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Alvimopan.


The risk or severity of adverse effects can be increased when dyclonine is combined with paroxetine.


The risk or severity of adverse effects can be increased when isoflurane is combined with amisulpride.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with prazepam.


The risk or severity of adverse effects can be increased when Butethal is combined with citalopram.


The risk or severity of adverse effects can be increased when imipramine is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when imipramine is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when Paliperidone is combined with fluvoxamine.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with flunisolide.


The risk or severity of adverse effects can be increased when medrysone is combined with norfloxacin.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when isoniazid is combined with D-cycloserine.


The risk or severity of adverse effects can be increased when tolazoline is combined with Eplerenone.


The risk or severity of adverse effects can be increased when dicyclomine is combined with hyoscyamine.


The risk or severity of adverse effects can be increased when butorphanol is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when pirenzepine is combined with Propiverine.


The risk or severity of adverse effects can be increased when Levetiracetam is combined with venlafaxine.


The risk or severity of adverse effects can be increased when Tixocortol is combined with ambenonium.


The risk or severity of adverse effects can be increased when Tiotropium is combined with Tapentadol.


The risk or severity of adverse effects can be increased when methadone is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with scopolamine.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when oxprenolol is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when metolazone is combined with Eprosartan.


The risk or severity of adverse effects can be increased when Demecarium is combined with pilocarpine.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with DESONIDE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with cyclothiazide.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with methylphenidate.


The risk or severity of adverse effects can be increased when timolol is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when moclobemide is combined with periciazine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with tiapride.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with benazepril.


The risk or severity of adverse effects can be increased when triazolam is combined with Etomidate.


The risk or severity of adverse effects can be increased when codeine is combined with Articaine.


The risk or severity of adverse effects can be increased when triazolam is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when triazolam is combined with bupivacaine.


The risk or severity of adverse effects can be increased when procarbazine is combined with Carbocisteine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with brotizolam.


The risk or severity of adverse effects can be increased when butorphanol is combined with thiothixene.


The risk or severity of adverse effects can be increased when quinapril is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with tolmetin.


The risk or severity of adverse effects can be increased when amodiaquine is combined with dapsone.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with cocaine.


The risk or severity of adverse effects can be increased when alclometasone is combined with malathion.


The risk or severity of adverse effects can be increased when bromazepam is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Vilazodone is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when methocarbamol is combined with felbamate.


The risk or severity of adverse effects can be increased when estazolam is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when alclometasone is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with meclizine.


The risk or severity of adverse effects can be increased when doxepin is combined with dantrolene.


The risk or severity of adverse effects can be increased when Eletriptan is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Retigabine.


The risk or severity of adverse effects can be increased when benazepril is combined with papaverine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Melatonin.


The risk or severity of adverse effects can be increased when methysergide is combined with Cobicistat.


The risk or severity of adverse effects can be increased when nimesulide is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when Torasemide is combined with enalapril.


The risk or severity of adverse effects can be increased when butalbital is combined with clonazepam.


The risk or severity of adverse effects can be increased when ondansetron is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with clonidine.


The risk or severity of adverse effects can be increased when ondansetron is combined with zotepine.


The risk or severity of adverse effects can be increased when ondansetron is combined with MELPERONE.


The risk or severity of adverse effects can be increased when fluoxetine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when CICLOPIROX is combined with Benidipine.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when tolterodine is combined with oxycodone.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with bromazepam.


The risk or severity of adverse effects can be increased when CICLOPIROX is combined with cilnidipine.


The risk or severity of adverse effects can be increased when clonazepam is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with desoximetasone.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when methscopolamine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when amiodarone is combined with Nabilone.


The risk or severity of adverse effects can be increased when amiodarone is combined with brimonidine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Icatibant.


The risk or severity of adverse effects can be increased when halothane is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when metaraminol is combined with METHAMPHETAMINE.


The risk or severity of adverse effects can be increased when quetiapine is combined with thiopental.


The risk or severity of adverse effects can be increased when halothane is combined with Metipranolol.


The risk or severity of adverse effects can be increased when halothane is combined with dantrolene.


The risk or severity of adverse effects can be increased when quetiapine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Normethadone is combined with felbamate.


The risk or severity of adverse effects can be increased when salicylamide is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with Etidocaine.


The risk or severity of adverse effects can be increased when mesoridazine is combined with glutethimide.


The risk or severity of adverse effects can be increased when bepridil is combined with metoprolol.


The risk or severity of adverse effects can be increased when dibucaine is combined with benzocaine.


The risk or severity of adverse effects can be increased when dibucaine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Tramadol is combined with dihydroergotamine.


The risk or severity of adverse effects can be increased when diflunisal is combined with formestane.


The risk or severity of adverse effects can be increased when benazepril is combined with hydralazine.


The risk or severity of adverse effects can be increased when diflunisal is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when sulconazole is combined with nisoldipine.


The risk or severity of adverse effects can be increased when Naloxegol is combined with Methylnaltrexone.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with zotepine.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when sotalol is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when betaxolol is combined with nicardipine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with desipramine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with promethazine.


The risk or severity of adverse effects can be increased when cocaine is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when thiamylal is combined with Fospropofol.


The risk or severity of adverse effects can be increased when Pentyl nitrite is combined with Aliskiren.


The risk or severity of adverse effects can be increased when Sitagliptin is combined with trandolapril.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when methylene blue is combined with Salbutamol.


The risk or severity of adverse effects can be increased when rescinnamine is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when rescinnamine is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when estazolam is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with Agomelatine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with triamterene.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with amisulpride.


The risk or severity of adverse effects can be increased when quinapril is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when sotalol is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when azelastine is combined with formestane.


The risk or severity of adverse effects can be increased when valsartan is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when trandolapril is combined with methazolamide.


The risk or severity of adverse effects can be increased when meperidine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when Lacidipine is combined with nitric oxide.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with Flibanserin.


The risk or severity of adverse effects can be increased when meperidine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with METAXALONE.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with protriptyline.


The risk or severity of adverse effects can be increased when Rufinamide is combined with amoxapine.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with niflumic acid.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with procaine.


The risk or severity of adverse effects can be increased when meperidine is combined with prazepam.


The risk or severity of adverse effects can be increased when cabergoline is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when sildenafil is combined with atorvastatin.


The risk or severity of adverse effects can be increased when prilocaine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when dibucaine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with Fesoterodine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with trazodone.


The risk or severity of adverse effects can be increased when doxazosin is combined with cilazapril.


The risk or severity of adverse effects can be increased when bromazepam is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when Toloxatone is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when clorazepate is combined with dyclonine.


The risk or severity of adverse effects can be increased when clorazepate is combined with propoxyphene.


The risk or severity of adverse effects can be increased when Methylscopolamine bromide is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when baclofen is combined with Olopatadine.


The risk or severity of adverse effects can be increased when valsartan is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when meperidine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when moclobemide is combined with mianserin.


The risk or severity of adverse effects can be increased when meperidine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Ramelteon is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when bupivacaine is combined with trazodone.


The risk or severity of adverse effects can be increased when bupivacaine is combined with mecamylamine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with triamterene.


The risk or severity of adverse effects can be increased when butalbital is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Agomelatine.


The risk or severity of adverse effects can be increased when lorazepam is combined with Fospropofol.


The risk or severity of adverse effects can be increased when zopiclone is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when Tramadol is combined with Frovatriptan.


The risk or severity of adverse effects can be increased when Tramadol is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when Tramadol is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when benazepril is combined with chloroquine.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when mecamylamine is combined with carvedilol.


The risk or severity of adverse effects can be increased when Tramadol is combined with trichlormethiazide.


The risk or severity of adverse effects can be increased when benazepril is combined with sulindac.


The risk or severity of adverse effects can be increased when indomethacin is combined with celecoxib.


The risk or severity of adverse effects can be increased when clozapine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Limaprost is combined with Vorapaxar.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with halothane.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with Eprosartan.


The risk or severity of adverse effects can be increased when clozapine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when ondansetron is combined with loratadine.


The risk or severity of adverse effects can be increased when midazolam is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when enflurane is combined with brotizolam.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with Fospropofol.


The risk or severity of adverse effects can be increased when haloprogin is combined with nisoldipine.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with diclofenac.


The risk or severity of adverse effects can be increased when oxycodone is combined with Potassium citrate.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with enalapril.


The risk or severity of adverse effects can be increased when barnidipine is combined with Lofexidine.


The risk or severity of adverse effects can be increased when D-mannitol is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when prilocaine is combined with paroxetine.


The risk or severity of adverse effects can be increased when Torasemide is combined with kanamycin.


The risk or severity of adverse effects can be increased when Torasemide is combined with IDARUBICIN.


The risk or severity of adverse effects can be increased when oxycodone is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with letrozole.


The risk or severity of adverse effects can be increased when pentazocine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with hydroxyurea.


The risk or severity of adverse effects can be increased when pentazocine is combined with scopolamine.


The risk or severity of adverse effects can be increased when gabapentin is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when fluocinonide is combined with norfloxacin.


The risk or severity of adverse effects can be increased when Pramocaine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with busulfan.


The risk or severity of adverse effects can be increased when alprazolam is combined with Flupentixol.


The risk or severity of adverse effects can be increased when flunisolide is combined with fleroxacin.


The risk or severity of adverse effects can be increased when Sacubitril is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when glutethimide is combined with imipramine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with thiamylal.


The risk or severity of adverse effects can be increased when etodolac is combined with azelastine.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Sacubitril is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when Icatibant is combined with difluprednate.


The risk or severity of adverse effects can be increased when Icatibant is combined with halcinonide.


The risk or severity of adverse effects can be increased when doxepin is combined with procarbazine.


The risk or severity of adverse effects can be increased when bumetanide is combined with streptozocin.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with salicylic acid.


The risk or severity of adverse effects can be increased when morphine is combined with ramipril.


The risk or severity of adverse effects can be increased when nisoldipine is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when fosinopril is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when flurazepam is combined with clomipramine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with baclofen.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with fexofenadine.


The risk or severity of adverse effects can be increased when enflurane is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when nitrazepam is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with rescinnamine.


The risk or severity of adverse effects can be increased when lithium ion is combined with brotizolam.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Metipranolol.


The risk or severity of adverse effects can be increased when Rotigotine is combined with Eprosartan.


The risk or severity of adverse effects can be increased when azelastine is combined with resveratrol.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when suprofen is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when suprofen is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when quazepam is combined with clidinium.


The risk or severity of adverse effects can be increased when codeine is combined with dantrolene.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with timolol.


The risk or severity of adverse effects can be increased when pimozide is combined with methocarbamol.


The risk or severity of adverse effects can be increased when pimozide is combined with methylphenidate.


The risk or severity of adverse effects can be increased when dicyclomine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when pimozide is combined with triprolidine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with amoxapine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with nortriptyline.


The risk or severity of adverse effects can be increased when lisinopril is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with imipramine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with trazodone.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with loratadine.


The risk or severity of adverse effects can be increased when Coenzyme Q10 is combined with DAPTOMYCIN.


The risk or severity of adverse effects can be increased when Articaine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when bifonazole is combined with nifedipine.


The risk or severity of adverse effects can be increased when promazine is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with suramin.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Flibanserin.


The risk or severity of adverse effects can be increased when methyldopa is combined with cilazapril.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when gabapentin is combined with clonidine.


The risk or severity of adverse effects can be increased when clarithromycin is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with prazepam.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when oxazepam is combined with meclizine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when lisinopril is combined with terazosin.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with niflumic acid.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Iloperidone.


The risk or severity of adverse effects can be increased when selegiline is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Retigabine.


The risk or severity of adverse effects can be increased when Bortezomib is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when methadone is combined with nortriptyline.


The risk or severity of adverse effects can be increased when estazolam is combined with Retigabine.


The risk or severity of adverse effects can be increased when phenobarbital is combined with Articaine.


The risk or severity of adverse effects can be increased when ISOSORBIDE MONONITRATE is combined with Bretylium.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with Ramelteon.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Telmisartan is combined with ibuprofen.


The risk or severity of adverse effects can be increased when Triflusal is combined with aspirin.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with promethazine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with tioconazole.


The risk or severity of adverse effects can be increased when Tolcapone is combined with prazosin.


The risk or severity of adverse effects can be increased when Tolcapone is combined with loratadine.


The risk or severity of adverse effects can be increased when buprenorphine is combined with potassium ion.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with venlafaxine.


The risk or severity of adverse effects can be increased when triflupromazine is combined with halothane.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with clemastine.


The risk or severity of adverse effects can be increased when diazepam is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when butenafine is combined with nimodipine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with methazolamide.


The risk or severity of adverse effects can be increased when METYROSINE is combined with droperidol.


The risk or severity of adverse effects can be increased when Perospirone is combined with clomipramine.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with tolterodine.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with lovastatin.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when zaleplon is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Metixene.


The risk or severity of adverse effects can be increased when thiopental is combined with ethosuximide.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with paramethasone.


The risk or severity of adverse effects can be increased when methocarbamol is combined with tiagabine.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when midodrine is combined with methoxamine.


The risk or severity of adverse effects can be increased when indomethacin is combined with azelastine.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Articaine.


The risk or severity of adverse effects can be increased when nefazodone is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when enalapril is combined with indapamide.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when diflunisal is combined with alclometasone.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Tixocortol.


The risk or severity of adverse effects can be increased when LEVOBUNOLOL is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with trimipramine.


The risk or severity of adverse effects can be increased when captopril is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when tolmetin is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when Phenelzine is combined with buspirone.


The risk or severity of adverse effects can be increased when Phenelzine is combined with oxycodone.


The risk or severity of adverse effects can be increased when pimozide is combined with ketamine.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with lithium ion.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with carvedilol.


The risk or severity of adverse effects can be increased when butorphanol is combined with scopolamine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with felodipine.


The risk or severity of adverse effects can be increased when Propiverine is combined with Tramadol.


The risk or severity of adverse effects can be increased when nicergoline is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with paramethasone.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when quinapril is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when pimozide is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when morphine is combined with nilvadipine.


The risk or severity of adverse effects can be increased when Pramocaine is combined with maprotiline.


The risk or severity of adverse effects can be increased when morphine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when ibudilast is combined with aspirin.


The risk or severity of adverse effects can be increased when triamcinolone is combined with cinoxacin.


The risk or severity of adverse effects can be increased when Phenelzine is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when nitric oxide is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when buprenorphine is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with thiothixene.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with carisoprodol.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with sulpiride.


The risk or severity of adverse effects can be increased when hydromorphone is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when hydromorphone is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when flunarizine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when duloxetine is combined with procarbazine.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when bupivacaine is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with Caspofungin.


The risk or severity of adverse effects can be increased when Saxagliptin is combined with fosinopril.


The risk or severity of adverse effects can be increased when oxazepam is combined with tiapride.


The risk or severity of adverse effects can be increased when Articaine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when methazolamide is combined with Nebivolol.


The risk or severity of adverse effects can be increased when propoxyphene is combined with clonidine.


The risk or severity of adverse effects can be increased when ethopropazine is combined with Tapentadol.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with cilazapril.


The risk or severity of adverse effects can be increased when linezolid is combined with Almotriptan.


The risk or severity of adverse effects can be increased when Telmisartan is combined with diflunisal.


The risk or severity of adverse effects can be increased when buspirone is combined with nalbuphine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with nitrendipine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when biperiden is combined with hydromorphone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with sevoflurane.


The risk or severity of adverse effects can be increased when amiodarone is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Trospium is combined with Butylscopolamine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with ropinirole.


The risk or severity of adverse effects can be increased when niflumic acid is combined with betamethasone.


The risk or severity of adverse effects can be increased when RIMEXOLONE is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when alprazolam is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when morphine is combined with amoxapine.


The risk or severity of adverse effects can be increased when Bortezomib is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when alprazolam is combined with Remoxipride.


The risk or severity of adverse effects can be increased when oxazepam is combined with HEROIN.


The risk or severity of adverse effects can be increased when thioridazine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when amcinonide is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when suprofen is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Metixene.


The risk or severity of adverse effects can be increased when itraconazole is combined with oxycodone.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Agomelatine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with timolol.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with doxepin.


The risk or severity of adverse effects can be increased when paramethasone is combined with enoxacin.


The risk or severity of adverse effects can be increased when lorazepam is combined with diazepam.


The risk or severity of adverse effects can be increased when levorphanol is combined with topiramate.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when halothane is combined with butamben.


The risk or severity of adverse effects can be increased when methylprednisolone is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with acemetacin.


The risk or severity of adverse effects can be increased when bupivacaine is combined with tiagabine.


The risk or severity of adverse effects can be increased when tubocurarine is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when HEROIN is combined with Pirlindole.


The risk or severity of adverse effects can be increased when HEROIN is combined with Toloxatone.


The risk or severity of adverse effects can be increased when mecamylamine is combined with Nebivolol.


The risk or severity of adverse effects can be increased when salicylic acid is combined with difluprednate.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with sulindac.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when sertraline is combined with thiothixene.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when zaleplon is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when thiothixene is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with Telmisartan.


The risk or severity of adverse effects can be increased when thiothixene is combined with fludiazepam.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with nadolol.


The risk or severity of adverse effects can be increased when primidone is combined with phenobarbital.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when METHAMPHETAMINE is combined with nylidrin.


The risk or severity of adverse effects can be increased when nitrendipine is combined with clonidine.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with procyclidine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Pirlindole.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Toloxatone.


The risk or severity of adverse effects can be increased when tamoxifen is combined with Ospemifene.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Methylnaltrexone.


The risk or severity of adverse effects can be increased when Tolcapone is combined with atenolol.


The risk or severity of adverse effects can be increased when pentazocine is combined with tetracaine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with brotizolam.


The risk or severity of adverse effects can be increased when alprazolam is combined with thioridazine.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with betamethasone.


The risk or severity of adverse effects can be increased when Efonidipine is combined with bumetanide.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with penbutolol.


The risk or severity of adverse effects can be increased when Efonidipine is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with doxepin.


The risk or severity of adverse effects can be increased when benzocaine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with METAXALONE.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with nefazodone.


The risk or severity of adverse effects can be increased when chloroquine is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when pentazocine is combined with cocaine.


The risk or severity of adverse effects can be increased when naratriptan is combined with doxepin.


The risk or severity of adverse effects can be increased when thiopental is combined with topiramate.


The risk or severity of adverse effects can be increased when pentazocine is combined with zonisamide.


The risk or severity of adverse effects can be increased when reserpine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when docetaxel is combined with tibolone.


The risk or severity of adverse effects can be increased when chloroquine is combined with Droxicam.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when LISURIDE is combined with Quinupristin.


The risk or severity of adverse effects can be increased when naratriptan is combined with nefazodone.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with Propacetamol.


The risk or severity of adverse effects can be increased when fosinopril is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when thalidomide is combined with penbutolol.


The risk or severity of adverse effects can be increased when methysergide is combined with acetazolamide.


The risk or severity of adverse effects can be increased when methysergide is combined with propofol.


The risk or severity of adverse effects can be increased when cilnidipine is combined with quetiapine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with hydralazine.


The risk or severity of adverse effects can be increased when METAXALONE is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when cocaine is combined with butamben.


The risk or severity of adverse effects can be increased when ceritinib is combined with oxycodone.


The risk or severity of adverse effects can be increased when Stepronin is combined with leflunomide.


The risk or severity of adverse effects can be increased when codeine is combined with Toloxatone.


The risk or severity of adverse effects can be increased when meprobamate is combined with nortriptyline.


The risk or severity of adverse effects can be increased when meprobamate is combined with amoxapine.


The risk or severity of adverse effects can be increased when clozapine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with Aliskiren.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Perospirone.


The risk or severity of adverse effects can be increased when Normethadone is combined with isocarboxazid.